DOCSLIB.ORG

Role of TXNIP Biology in Glucose Metabolism Alec B Chaves1, Jacob M Haus2 and Joseph a Houmard1*

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Role of TXNIP Biology in Glucose Metabolism Alec B Chaves1, Jacob M Haus2 and Joseph a Houmard1* ISSN: 2377-3634 Chaves et al. Int J Diabetes Clin Res 2018, 5:080 DOI: 10.23937/2377-3634/1410080 Volume 5 | Issue 1 International Journal of Open Access Diabetes and Clinical Research REVIEW ARTICLE Role of TXNIP Biology in Glucose Metabolism Alec B Chaves1, Jacob M Haus2 and Joseph A Houmard1* 1 Check for Department of Kinesiology, East Carolina University, Greenville, USA updates 2Department of Kinesiology and Nutrition, University of Illinois Chicago, Chicago, USA *Corresponding author: Joseph A Houmard, Ph.D, Department of Kinesiology, Human Performance Laboratory East Carolina University, Greenville, NC, USA, Tel: 252-737-4617, E-mail: [email protected] Abstract Protein; P300: Histone Acetyltransferase p300; PA: Palmi- tic Acid; NAC: N-Acetyl-L-cysteine; AMPK: AMP-Activated Skeletal muscle insulin resistance is a major contributor to Protein Kinase; SIRT1: Sirtuin 1; NLRP3: NOD-Like Recep- the natural history of type 2 diabetes mellitus. A common tor P3; PERK: PKR-like ER Resident Kinase; ATF6: Activa- underpinning that exists behind the mechanisms of insulin ting Transcription Factor 6 resistance is the overproduction of reactive oxygen species, which may be exacerbated by a protein target known as thioredoxin-interacting protein (TXNIP). TXNIP is a member Introduction of the α-arrestin protein family that is capable of suppres- sing glucose metabolism in several tissues. Cross sectio- Type II diabetes (T2DM) is a debilitating disease that nal analysis reveals that individuals with insulin resistance, places significant economic burden on the healthcare impaired glucose tolerance, and type II diabetes have ele- system with over $245 billion in annual costs affecting vated protein and mRNA expression of TXNIP in skeletal muscle compared to lean healthy controls, which negatively over 30 million Americans [1]. T2DM is characterized by correlates with insulin sensitivity. The goal of this review is chronic hyperglycemia which promotes oxidative stress to explore TXNIP’s role in glucose metabolism and provide and inflammation in multiple tissues. If left untreated, mechanisms through which it can be regulated to provide T2DM can lead to an increased risk of heart disease, potential targets for future research and therapeutic inter- kidney failure, and augmented cognitive decline [2-5]. ventions for the treatment of insulin resistance. Although T2DM requires the coordinated dysfunction Keywords of several tissues, understanding the molecular mecha- Diabetes, Insulin resistance, TXNIP, Exercise nisms that promote insulin resistance in skeletal muscle should be a chief concern, as this tissue is the primary List of Abbreviations site for insulin-mediated glucose metabolism [6]. A pro- T2DM: Type II Diabetes; TXNIP: Thioredoxin Interacting Pro- tein that has gained recent attention in relation to the tein; REDD1: Regulated in Development and DNA Damage regulation of insulin action at the level of the skeletal Responses 1; TRX: Thioredoxin; NGT: Normal Glucose Tolerant; IGT: Impaired Glucose Tolerant; ASK1: Apopto- muscle, is thioredoxin-interacting protein (TXNIP). tic Signaling Kinase; PTEN: Phosphatase Tensin Homolog TXNIP description and domain analysis 10; REF-1: Redox Factor-1; HIF-1: Hypoxia-Inducible Fac- tor-1a; NF-κB: Nuclear Factor Kappa-Light-Chain-Enhan- TXNIP, also referred to as Vitamin-D upregulated cer of Activated B Cells; AP-1: Activator Protein-1; NRF-2: protein 1 (VDUP-1), was first discovered in HL-60 leu- Nuclear Factor E2-Related Factor 2; GR: Glucocorticoid Receptor; ER: Estrogen Receptor; ETC: Electron Transport kemia cells and shown to be upregulated in response Chain; AICAR: 5-Aminoimidazole-4-Carboxamide Ribo- to treatment with 1,25-dihydroxyvitamin D3 [7]. Subse- nucleotide; PBMC: Peripheral Blood Mononuclear Cells; quent investigations utilizing two-hybrid yeast analysis PP2A: Protein Phosphatase 2; AKT: Protein Kinase B; P38 revealed that TXNIP is capable of binding to cysteine MAPK: P38 Mitogen-Activated Protein Kinase; FOXO1: For- khead Box 01 Transcriptional Factor; CCP: Clathrin Coated residues located within the active site of antioxidan- Pits; CHREBP: Carbohydrate Response Element Binding ts Thioredoxin-1 (TRX-1) and 2 (TRX-2) and inhibiting Citation: Chaves AB, Haus JM, Houmard JA (2018) Role of TXNIP Biology in Glucose Metabolism. Int J Diabetes Clin Res 4:080. doi.org/10.23937/2377-3634/1410080 Received: November 17, 2017: Accepted: January 06, 2018: Published: January 08, 2018 Copyright: © 2018 Chaves AB, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Chaves et al. Int J Diabetes Clin Res 2018, 5:080 • Page 1 of 5 • DOI: 10.23937/2377-3634/1410080 ISSN: 2377-3634 their ability to scavenge reactive oxygen species thus cellular level, a preclinical model with liver-specific de- promoting oxidative stress [8]. Although TXNIP belon- letion of TXNIP was developed. With TXNIP deletion, he- gs to the α-arrestin protein family, the active cysteine patic glucose production was blunted which led to hypo- residues that enable its interaction with TRX are not glycemia during the fasted state. However, in response present in other members of the family, indicating that to a glucose challenge, liver-specific TXNIP knockout TXNIP has the distinct ability to bind to the active site mice were incapable of achieving greater glucose clea- of TRX and affect the redox environment [9]. Spindel, rance rates compared to their wildtype littermates. This et al. [10] conducted three-dimensional (3D) analysis of finding is in contrast with systemic knockout models TXNIP and determined that TXNIP contains several do- indicating that although fasting glucose homeostasis mains that are conserved amongst other members of is modulated by hepatocyte TXNIP levels; postprandial the α-arrestin family and are necessary for its redox-in- glucose tolerance may require modulation of TXNIP bio- dependent functions. Within the n-terminus there are logy in other tissues and cell types [19]. two SH3-binding domains which are known to interact with non-tyrosine kinase Src, and a mitogen activated DeBalsi, et al. [20] developed a skeletal muscle-spe- protein kinase kinase kinase 5 (MAP3K-5) [10-12]. Con- cific TXNIP knockout (SKM-/-) murine model. Compari- versely, within the C-terminus lies three SH3-binding sons between the whole-body knockout, skeletal mu- domains and two PPxY motifs. The PPxY motifs are ne- scle-specific knockout, and wild type revealed that glu- cessary for TXNIP to interact with E3 Ubiqutin Ligase, cose tolerance was enhanced (i.e. lowered circulating Itch, enabling it to undergo polyubiquitination and sub- glucose concentrations) in the whole-body knockout sequent proteasome degradation [13]. Recent evidence model following an intraperitoneal glucose tolerance suggests that following phosphorylation of a specific se- test. Interestingly, these improvements were preserved rine residue, ser308, TXNIP undergoes a conformational in the SKM (-/-) specific knockout indicating that skele- change that increases its susceptibility to ubiquitination tal muscle expression of TXNIP contributes significantly via Itch, augmenting its rate of proteasome degrada- to whole-body glucose homeostasis. Although SKM (-/-) tion [14]. TXNIP also contains two additional domains specific TXNIP deficiency improved glucose tolerance, including immune-receptor tyrosine-based inhibition the mice also experienced reduced mitochondrial respi- domain (ITIM) and chromatin maintenance region 1 ration, substrate oxidation, mitochondrial protein mar- (CRM1) [10]. ITIM mediates TXNIP’s interaction with kers, and aerobic exercise capacity. These data suggest tyrosine phosphatases in order to regulate the intracel- that TXNIP serves as a metabolic switch between oxida- lular activity of membrane-bound receptors [15]. CRM1 tive and glycolytic metabolism, and must be regulated mediates the interaction with hypoxia-inducible factor appropriately to achieve proper balance between ener- 1-α (HIF1-α) and ubiquitin ligase von Hippel-Lindau pro- gy systems. tein (pVHL), leading to the exclusion of HIF1-α from the Despite extensive work conducted on TXNIP expres- nucleus and degradation in the cytosol [16]. sion and glucose metabolism, the mechanism through Role of TXNIP in glucose metabolism which TXNIP exerted these effects was still largely un- known. Oslowski, et al. [21] provided some initial insi- TXNIP’s role in regulating metabolism was first inve- ght by demonstrating in pancreatic β-cells that TXNIP stigated in HcB-19 mice used as a preclinical model to can interact and mediate the activation of the nod like study familial hypercholesterolemia in humans. Intere- receptor P3 (NLRP3) inflammasome, which is a large stingly, the hypocholesteremia was a result of a sponta- multimeric protein complex, capable of inducing en- neous mutation on the TXNIP gene leading to systemic doplasmic reticulum (ER) stress, IL-1β expression, and reductions at the mRNA levels. As a result, HcB-19 mice apoptotic cell death. These findings were substantiated had lower basal CO2 production, increased triglyceride in microvascular endothelial cells by demonstrating that synthesis, and decreased flux of free fatty acids (FFA) silencing of TXNIP ameliorated NLRP3 activation in -re through the tricarboxylic acid (TCA) cycle [17]. Conside- sponse to oxidative stress [22]. Further,
Load more

Recommended publications
  • The Thioredoxin Trx-1 Regulates the Major Oxidative Stress Response Transcription Factor, Skn-1, in Caenorhabditis Elegans
    The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 5-2016 THE THIOREDOXIN TRX-1 REGULATES THE MAJOR OXIDATIVE STRESS RESPONSE TRANSCRIPTION FACTOR, SKN-1, IN CAENORHABDITIS ELEGANS Katie C. McCallum Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Cellular and Molecular Physiology Commons, Medicine and Health Sciences Commons, Molecular Genetics Commons, and the Organismal Biological Physiology Commons Recommended Citation McCallum, Katie C., "THE THIOREDOXIN TRX-1 REGULATES THE MAJOR OXIDATIVE STRESS RESPONSE TRANSCRIPTION FACTOR, SKN-1, IN CAENORHABDITIS ELEGANS" (2016). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 655. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/655 This Dissertation (PhD) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. THE THIOREDOXIN TRX-1 REGULATES THE MAJOR OXIDATIVE STRESS RESPONSE TRANSCRIPTION FACTOR, SKN-1, IN CAENORHABDITIS ELEGANS A DISSERTATION Presented to the Faculty of The University of Texas Health Science Center at Houston and The University of Texas MD Anderson Cancer Center Graduate School of Biomedical Sciences in Partial Fulfillment of the Requirements for the Degree of DOCTOR OF PHILOSOPHY by Katie Carol McCallum, B.S.
    [Show full text]
  • Minireview: Thioredoxin-Interacting Protein: Regulation and Function in the Pancreatic ␤-Cell
    MINIREVIEW Minireview: Thioredoxin-Interacting Protein: Regulation and Function in the Pancreatic ␤-Cell Anath Shalev Comprehensive Diabetes Center and Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Alabama at Birmingham, Birmingham, Alabama 35294 Pancreatic ␤-cells are responsible for insulin production, and loss of functional ␤-cell mass is now recognized as a critical step in the pathogenesis of both type 1 and type 2 diabetes. However, the factors controlling the life and death of the pancreatic ␤-cell have only started to be elucidated. Discovered as the top glucose-induced gene in a human islet microarray study 12 years ago, thioredoxin-interacting protein (TXNIP) has now emerged as such a key player in pancreatic ␤-cell biology. Since then, ␤-cell expression of TXNIP has been found to be tightly regulated by multiple factors and to be dramatically increased in diabetic islets. Elevated TXNIP levels induce ␤-cell apoptosis, whereas TXNIP deficiency protects against type 1 and type 2 diabetes by promoting ␤-cell survival. TXNIP interacts with and inhibits thioredoxin and thereby controls the cellular redox state, but it also belongs to the ␣-arrestin family of proteins and regulates a variety of metabolic processes. Most recently, TXNIP has been discovered to control ␤-cell microRNA expres- sion, ␤-cell function, and insulin production. In this review, the current state of knowledge re- garding regulation and function of TXNIP in the pancreatic ␤-cell and the implications for drug development are discussed. (Molecular Endocrinology 28: 1211–1220, 2014) he gene encoding thioredoxin-interacting protein hypoglycemia and elevated plasma insulin, triglycerides, T(TXNIP) was first cloned in 1994 (20 years ago) from ketone bodies, and free fatty acids (8, 9).
    [Show full text]
  • Domain Structure of the Glucocorticoid Receptor Protein
    Proc. Nati. Acad. Sci. USA Vol. 84, pp. 4437-4440, July 1987 Biochemistry Domain structure of the glucocorticoid receptor protein (proteolysis/steroid binding/DNA binding/protein sequence) JAN CARLSTEDT-DUKE*, PER-ERIK STROMSTEDT*, ORJAN WRANGEt, TOMAS BERGMANt, JAN-AKE GuSTAFSSON*, AND HANS JORNVALLf *Department of Medical Nutrition, Karolinska Institute, Huddinge University Hospital, F69, S-141 86 Huddinge, Sweden; and Departments of tMedical Cell Genetics and tChemistry, Karolinska Institute, Box 60400, S-104 01 Stockholm, Sweden Communicated by Viktor Mutt, March 26, 1987 (receivedfor review December 1, 1986) ABSTRACT The purified rat liver glucocorticoid receptor GR was eluted with 27.5 mM MgCl2 and further purified by protein was analyzed by limited proteolysis and amino acid chromatography on DEAE-Sepharose, eluted with a linear sequence determination. The NH2 terminus appears to be NaCl gradient. The receptor was detected by analysis for 3H blocked. The steroid-binding domain, defined by a unique radioactivity. Each purification resulted in a yield of '50 ,g tryptic cleavage site, corresponds to the COOH-terminal part of GR, starting from eight rat livers. The purified prepara- of the protein with the domain border in the region of residue tions of GR contained the 94-kDa GR, the 72-kDa GR- 518. The DNA-binding domain, defined by a region with associated protein that is unrelated to GR (12, 13), as well as chymotryptic cleavage sites, is immediately adjacent to the very small amounts of proteolytic GR fragments (usually steroid-binding domain and reflects another domain border in <5% of total protein according to densitometric analysis of the region of residues 410-414.
    [Show full text]
  • Role of Thioredoxin-Interacting Protein in Diseases and Its Therapeutic Outlook
    International Journal of Molecular Sciences Review Role of Thioredoxin-Interacting Protein in Diseases and Its Therapeutic Outlook Naila Qayyum 1,†, Muhammad Haseeb 1,† , Moon Suk Kim 1 and Sangdun Choi 1,2,* 1 Department of Molecular Science and Technology, Ajou University, Suwon 16499, Korea; [email protected] (N.Q.); [email protected] (M.H.); [email protected] (M.S.K.) 2 S&K Therapeutics, Woncheon Hall 135, Ajou University, Suwon 16499, Korea * Correspondence: [email protected] † These authors contributed equally to this work. Abstract: Thioredoxin-interacting protein (TXNIP), widely known as thioredoxin-binding protein 2 (TBP2), is a major binding mediator in the thioredoxin (TXN) antioxidant system, which involves a reduction-oxidation (redox) signaling complex and is pivotal for the pathophysiology of some diseases. TXNIP increases reactive oxygen species production and oxidative stress and thereby contributes to apoptosis. Recent studies indicate an evolving role of TXNIP in the pathogenesis of complex diseases such as metabolic disorders, neurological disorders, and inflammatory illnesses. In addition, TXNIP has gained significant attention due to its wide range of functions in energy metabolism, insulin sensitivity, improved insulin secretion, and also in the regulation of glucose and tumor suppressor activities in various cancers. This review aims to highlight the roles of TXNIP in the field of diabetology, neurodegenerative diseases, and inflammation. TXNIP is found to be a promising novel therapeutic target in the current review, not only in the aforementioned diseases but also in prolonged microvascular and macrovascular diseases. Therefore, TXNIP inhibitors hold promise for preventing the growing incidence of complications in relevant diseases.
    [Show full text]
  • Is Glyceraldehyde-3-Phosphate Dehydrogenase a Central Redox Mediator?
    1 Is glyceraldehyde-3-phosphate dehydrogenase a central redox mediator? 2 Grace Russell, David Veal, John T. Hancock* 3 Department of Applied Sciences, University of the West of England, Bristol, 4 UK. 5 *Correspondence: 6 Prof. John T. Hancock 7 Faculty of Health and Applied Sciences, 8 University of the West of England, Bristol, BS16 1QY, UK. 9 [email protected] 10 11 SHORT TITLE | Redox and GAPDH 12 13 ABSTRACT 14 D-Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is an immensely important 15 enzyme carrying out a vital step in glycolysis and is found in all living organisms. 16 Although there are several isoforms identified in many species, it is now recognized 17 that cytosolic GAPDH has numerous moonlighting roles and is found in a variety of 18 intracellular locations, but also is associated with external membranes and the 19 extracellular environment. The switch of GAPDH function, from what would be 20 considered as its main metabolic role, to its alternate activities, is often under the 21 influence of redox active compounds. Reactive oxygen species (ROS), such as 22 hydrogen peroxide, along with reactive nitrogen species (RNS), such as nitric oxide, 23 are produced by a variety of mechanisms in cells, including from metabolic 24 processes, with their accumulation in cells being dramatically increased under stress 25 conditions. Overall, such reactive compounds contribute to the redox signaling of the 26 cell. Commonly redox signaling leads to post-translational modification of proteins, 27 often on the thiol groups of cysteine residues. In GAPDH the active site cysteine can 28 be modified in a variety of ways, but of pertinence, can be altered by both ROS and 29 RNS, as well as hydrogen sulfide and glutathione.
    [Show full text]
  • AMPK Attenuates Adriamycin-Induced Oxidative Podocyte Injury
    Molecular Pharmacology Fast Forward. Published on December 30, 2013 as DOI: 10.1124/mol.113.089458 Molecular PharmacologyThis article Fast has not Forward. been copyedited Published and formatted. on TheDecember final version 30, may 2013 differ asfrom doi:10.1124/mol.113.089458 this version. MOL #89458 AMPK Attenuates Adriamycin-Induced Oxidative Podocyte Injury through Thioredoxin-Mediated Suppression Downloaded from of ASK1-P38 Signaling Pathway molpharm.aspetjournals.org Kun Gao, Yuan Chi, Wei Sun, Masayuki Takeda and Jian Yao Departments of Molecular Signaling (K.G., Y.C., J.Y.), Interdisciplinary Graduate School of at ASPET Journals on September 30, 2021 Medicine and Engineering, University of Yamanashi, Yamanashi, Japan; Department of Nephrology (K.G., W.S.), Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China; and Department of Urology (M.T.), Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Yamanashi, Japan 1 Copyright 2013 by the American Society for Pharmacology and Experimental Therapeutics. Molecular Pharmacology Fast Forward. Published on December 30, 2013 as DOI: 10.1124/mol.113.089458 This article has not been copyedited and formatted. The final version may differ from this version. MOL #89458 Running title: AMPK attenuates oxidative cell injury Address correspondence to: Jian Yao, M.D., Ph.D., Department of Molecular Signaling, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Chuo, Yamanashi 409-3898, Japan. Tel/Fax:
    [Show full text]
  • Thioredoxin Interacting Protein (TXNIP) Rs7212 Polymorphism Is Associated with Arterial Stiffness in the Brazilian General Population
    Journal of Human Hypertension (2012) 26, 340 --342 & 2012 Macmillan Publishers Limited All rights reserved 0950-9240/12 www.nature.com/ RESEARCH LETTER Thioredoxin interacting protein (TXNIP) rs7212 polymorphism is associated with arterial stiffness in the Brazilian general population Journal of Human Hypertension (2012) 26, 340 --342; been previously described.8 TXNIP rs7212 was chosen based on doi:10.1038/jhh.2011.102; published online 24 November 2011 the previous association of this marker with diabetes in the Brazilian population (Ferreira, NE, unpublished results). In the Thioredoxin interacting protein plays a pivotal role in several present study it was detected by polymerase chain reaction- important processes of cardiovascular homeostasis by func- restriction fragment length polymorphism assay. A 30--cycle PCR tioning as a biological sensor for biomechanical and oxidative was carried out using a 10 ml reactive solution containing (10 mM stress. However, the effects of genetic variants in the Tris-HCl, pH 9.0; 50 mM KCl; 2.5 mM MgCl2; 100 mM of each dNTP; 0.3 modulation of arterial stiffness are unknown. In this scenario, U Taq DNA Polymerase; 5 pmol of each primer; 50 ng of genomic the present study evaluated the relationship between the DNA template). PCR products were digested with 1 U of the HaeIII TXNIP rs7212 polymorphism and arterial stiffness. In the restriction enzyme and visualized by 3% agarose gel electrophor- overall sample and in the diabetic group, individuals carrying esis. Quality control was assessed by re-genotyping of 40 samples CG þ GG genotypes had higher PWV values compared with CC randomly selected and gave identical results in all tests.
    [Show full text]
  • Mondoa Drives Muscle Lipid Accumulation and Insulin Resistance
    MondoA drives muscle lipid accumulation and insulin resistance Byungyong Ahn, … , Kyoung Jae Won, Daniel P. Kelly JCI Insight. 2019. https://doi.org/10.1172/jci.insight.129119. Research In-Press Preview Metabolism Muscle biology Obesity-related insulin resistance is associated with intramyocellular lipid accumulation in skeletal muscle. We hypothesized that in contrast to current dogma, this linkage is related to an upstream mechanism that coordinately regulates both processes. We demonstrate that the muscle-enriched transcription factor MondoA is glucose/fructose responsive in human skeletal myotubes and directs the transcription of genes in cellular metabolic pathways involved in diversion of energy substrate from a catabolic fate into nutrient storage pathways including fatty acid desaturation and elongation, triacylglyeride (TAG) biosynthesis, glycogen storage, and hexosamine biosynthesis. MondoA also reduces myocyte glucose uptake by suppressing insulin signaling. Mice with muscle-specific MondoA deficiency were partially protected from insulin resistance and muscle TAG accumulation in the context of diet-induced obesity. These results identify MondoA as a nutrient-regulated transcription factor that under normal physiological conditions serves a dynamic checkpoint function to prevent excess energy substrate flux into muscle catabolic pathways when myocyte nutrient balance is positive. However, in conditions of chronic caloric excess, this mechanism becomes persistently activated leading to progressive myocyte lipid storage and insulin resistance. Find the latest version: https://jci.me/129119/pdf Revised manuscript JCI Insight 129119-INS-RG-RV-3 MondoA Drives Muscle Lipid Accumulation and Insulin Resistance Byungyong Ahn1, Shibiao Wan2, Natasha Jaiswal2, Rick B. Vega3, Donald E. Ayer4, Paul M. Titchenell2, Xianlin Han5, Kyoung Jae Won2, Daniel P.
    [Show full text]
  • Role of Transglutaminase 2 in Cell Death, Survival, and Fibrosis
    cells Review Role of Transglutaminase 2 in Cell Death, Survival, and Fibrosis Hideki Tatsukawa * and Kiyotaka Hitomi Cellular Biochemistry Laboratory, Graduate School of Pharmaceutical Sciences, Nagoya University, Tokai National Higher Education and Research System, Nagoya 464-8601, Aichi, Japan; [email protected] * Correspondence: [email protected]; Tel.: +81-52-747-6808 Abstract: Transglutaminase 2 (TG2) is a ubiquitously expressed enzyme catalyzing the crosslink- ing between Gln and Lys residues and involved in various pathophysiological events. Besides this crosslinking activity, TG2 functions as a deamidase, GTPase, isopeptidase, adapter/scaffold, protein disulfide isomerase, and kinase. It also plays a role in the regulation of hypusination and serotonylation. Through these activities, TG2 is involved in cell growth, differentiation, cell death, inflammation, tissue repair, and fibrosis. Depending on the cell type and stimulus, TG2 changes its subcellular localization and biological activity, leading to cell death or survival. In normal unstressed cells, intracellular TG2 exhibits a GTP-bound closed conformation, exerting prosurvival functions. However, upon cell stimulation with Ca2+ or other factors, TG2 adopts a Ca2+-bound open confor- mation, demonstrating a transamidase activity involved in cell death or survival. These functional discrepancies of TG2 open form might be caused by its multifunctional nature, the existence of splicing variants, the cell type and stimulus, and the genetic backgrounds and variations of the mouse models used. TG2 is also involved in the phagocytosis of dead cells by macrophages and in fibrosis during tissue repair. Here, we summarize and discuss the multifunctional and controversial Citation: Tatsukawa, H.; Hitomi, K. roles of TG2, focusing on cell death/survival and fibrosis.
    [Show full text]
  • Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation
    BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in
    [Show full text]
  • AMP-Activated Protein Kinase: the Current Landscape for Drug Development
    REVIEWS AMP-activated protein kinase: the current landscape for drug development Gregory R. Steinberg 1* and David Carling2 Abstract | Since the discovery of AMP-activated protein kinase (AMPK) as a central regulator of energy homeostasis, many exciting insights into its structure, regulation and physiological roles have been revealed. While exercise, caloric restriction, metformin and many natural products increase AMPK activity and exert a multitude of health benefits, developing direct activators of AMPK to elicit beneficial effects has been challenging. However, in recent years, direct AMPK activators have been identified and tested in preclinical models, and a small number have entered clinical trials. Despite these advances, which disease(s) represent the best indications for therapeutic AMPK activation and the long-term safety of such approaches remain to be established. Cardiovascular disease Dramatic improvements in health care coupled with identifying a unifying mechanism that could link these (CVD). A term encompassing an increased standard of living, including better nutri- changes to multiple branches of metabolism followed diseases affecting the heart tion and education, have led to a remarkable increase in the discovery that the AMP-activated protein kinase or circulatory system. human lifespan1. Importantly, the number of years spent (AMPK) provided a common regulatory mechanism in good health is also increasing2. Despite these positive for inhibiting both cholesterol (through phosphoryla- Non-alcoholic fatty liver disease developments, there are substantial risks that challenge tion of HMG-CoA reductase (HMGR)) and fatty acid (NAFLD). A very common continued improvements in human health. Perhaps the (through phosphorylation of acetyl-CoA carboxylase disease in humans in which greatest threat to future health is a chronic energy imbal- (ACC)) synthesis8 (BOx 1).
    [Show full text]
  • Thioredoxin-Interacting Protein (Txnip) Is a Glucocorticoid-Regulated Primary Response Gene Involved in Mediating Glucocorticoid-Induced Apoptosis
    Oncogene (2006) 25, 1903–1913 & 2006 Nature Publishing Group All rights reserved 0950-9232/06 $30.00 www.nature.com/onc ORIGINAL ARTICLE Thioredoxin-interacting protein (txnip) is a glucocorticoid-regulated primary response gene involved in mediating glucocorticoid-induced apoptosis Z Wang, YP Rong, MH Malone, MC Davis, F Zhong and CW Distelhorst Departments of Medicine and Pharmacology, Comprehensive Cancer Center, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, OH, USA Glucocorticoid hormones induce apoptosis in lymphoid Introduction cells.This process is transcriptionally regulated and requires de novo RNA/protein synthesis.However, the Glucocorticoid-induced apoptosis plays an important full spectrum of glucocorticoid-regulated genes mediating physiological role, contributing to maintenance of this cell death process is unknown.Through gene homeostasis in the immune system (Ashwell et al., expression profiling we discovered that the expression 2000; Jondal et al., 2004). As their ability to induce of thioredoxin-intereacting protein (txnip) mRNA is apoptosis in immature lymphocytes, glucocorticoids significantly induced by the glucocorticoid hormone dexa- (dexamethasone, prednisone) are among the most methasone not only in the murine T-cell lymphoma line effective agents for treatment of lymphoid malignancies WEHI7.2, but also in normal mouse thymocytes. This (Schmidt et al., 2004). However, their therapeutic use is result was confirmed by Northern blot analysis in multiple limited
    [Show full text]